Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-003749-14Phase 2
Phase 2, randomised trial of sodium sulfate + potassium sulfate + magnesium sulfate in None (2 arms), sponsored by Braintree Laboratories. Primary endpoint: Percent of subjects with treatment emergent adverse events.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-003749-14.